Women refusing HBs Ag test
HIV co-infection
HCV co-infection
HBV treatment ongoing at the day of inclusion
Creatinine clearance < 30 mL/min
Severe gravidic disease present at inclusion involving life threatening to the mother and/or the child
Evidence of pre-existing fetal anomalies incompatible with the child's life
Imminent child's birth defined as cervix dilatation up to 7 centimeters
Intention to deliver in a maternity not linked to the study
Any concomitant medical condition that, according to the clinical site investigator would contraindicate participation in the study.
Concurrent participation in any other clinical trial without written agreement of the two study teams

NCT02937779_exc_T1
Measurement
HBs Ag test
NCT02937779_exc_T2
Negation
refusing
NCT02937779_exc_T3
Condition
co-infection
NCT02937779_exc_T4
Condition
co-infection
NCT02937779_exc_T5
Qualifier
HIV
NCT02937779_exc_T6
Qualifier
HCV
NCT02937779_exc_T7
Procedure
HBV treatment
NCT02937779_exc_T8
Measurement
Creatinine clearance
NCT02937779_exc_T9
Value
< 30 mL/min
NCT02937779_exc_T10
Condition
gravidic disease
NCT02937779_exc_T11
Qualifier
Severe
NCT02937779_exc_T12
Qualifier
life threatening
NCT02937779_exc_T13
Condition
fetal anomalies
NCT02937779_exc_T14
Condition
Imminent child's birth
NCT02937779_exc_T15
Measurement
cervix dilatation
NCT02937779_exc_T16
Value
7 centimeters